On January 4, Medtronic, Inc., announced the approval of its novel mySentry Remote Glucose Monitor, a first-of-its-kind device that allows parents and other caregivers to monitor a person’s glucose trends and insulin pump functions from another room.
The mySentry is composed of a monitor with a color screen and a mySentry Outpost device, which transmits information from the Minimed Paradigm Real-Time Revel System — an insulin pump with built-in continuous glucose monitoring — to the monitor.
The Outpost can communicate from more than 50 feet away to the mySentry monitor, transmitting information that includes continuous glucose monitoring graphs, insulin pump battery life, amount of insulin remaining, and time until the next glucose sensor calibration. The mySentry sounds the same alarms as the Minimed Paradigm Real-Time Revel System, alerting caregivers to impending low or high blood glucose levels and notifying when preset low or high blood glucose levels have been reached. Volumes on the alarms can be adjusted, and alarms can sound loudly to awaken deep sleepers. The device also features a snooze button to temporarily silence alarms.
The mySentry monitor uses touch-sensitive display technology and can be adjusted to varying levels of brightness. An optional privacy display screen is also available to hide sensitive information while allowing alerts to come through.
“Many of the parents of our patients wake up a couple of times every night to check their child’s blood sugar level and even that may not be enough to prevent episodes of severe hypoglycemia,” notes William Tamborlane, MD, Chief of Pediatric Endocrinology and Deputy Director of the Yale Center for Clinical Investigation. “Advances in continuous glucose monitoring, including remote monitoring like mySentry, have given parents an added level of protection from dangerous nighttime hypoglycemia occurring in their sleeping child, as well as a means to improve their quality of life.”
According to the Medtronic press release, the company is “committed to working with health insurance providers to ensure access to and reimbursement for the product.” The mySentry system, which is available for order immediately, costs about $3,000, but Medtronic is offering it at a special promotional price of $2,400 for a limited time. The company is also offering another $500 off for new customers who purchase an insulin pump, continuous glucose monitor, and mySentry in their initial order. Financial assistance is additionally available from Medtronic for customers who meet certain income requirements. Call (800) 646-4633 for more information.
To learn more about the Medtronic mySentry Monitor, read the article “Medtronic mySentry Lets You Watch Your Kid’s Glucose Through the Night,” or see the mySentry page on the Medtronic Web site (which also includes a video illustrating how the device works). And for more information on the MiniMed Paradigm REAL-Time Revel System, click here.